Gastroenterology

Pharma News for Gilead, Roche, AstraZeneca, Genentech, Mirati, Pfizer

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Gilead Sciences’ Sunlenca Approval; FDA Approves Roche’s CD20xCD3 Bispecific Antibody Lunsumio; EU Approves AstraZeneca’s Imfinzi Plus Chemo; Pfizer Files Blockbuster Hope Etrasimod for Ulcerative Colitis; FDA Approves Mosunetuzumab for R/F Follicular Lymphoma; FDA Breakthrough Therapy Designation to Adagrasib Plus Cetuximab for KRAS G12C–Mutated Advanced CRC

FDA Approves Gilead Sciences’ Sunlenca Sunlenca, a Gilead Sciences therapy for people with multidrug-resistant (MDR) HIV infection that only needs to be taken twice a year, has received FDA approval for the second time of asking. Sunlenca, which is based on the HIV capsid inhibitor lenacapavir, is intended to be used in addition to current HIV treatment. In trials, 81% of participants on the regimen achieved HIV RNA suppression, meaning their HIV levels were low enough to be considered undetectable after 6 months, with 83% showing continued viral load suppression after a year. The drug was rejected by the US regulator earlier this year, just a few months after t...

Explore More...

recent-pharma-biotech-news-updates-for-ikena-terns-ribometrix-hologic

FDA’s Ok to Roche’s Oral SMA Therapy; Roche’s Etrolizumab Mixed Results in Ulcerative Colitis; Secura receives rights to Copiktra from Verastem

Orchard licenses gene therapy tech from GSK; Glympse raises $46M; FDA voted to recommend Terlipressin; Breast Cancer research update

AZ sells EU rights for Schizophrenia to Cheplapharm; Astellas, Pandion unite to extract the potential of immunomodulation; Pear therapeutics on a journey to develop digital GI treatments with Ironwood

AZ announces positive results for durvalumab and tremelimumab; FDA nods to extend LILETTA’s use to prevent pregnancy; Gilead, Glympse Bio teams up to advance NASH clinical development

Rapt Therapeutics files IPO; Novartis stakes $80M for NASH

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Gastroenterology

Ikena bags $120M; Terns raises $87M for NASH; Ribometrix Genentech Collaboration; Hologic acquires Biotheranostics

The State of Alternative Medicine In The Healthcare

Healthcare Delivery System: What lies in the future?

What Can Help Manage The Insufficient Pancreas?

Nutrition Intervention: Foods to take and foods to avoid when suffering from Gastroparesis

New Hopes; New Horizons: Gastroparesis Market Has Mighty Treatment Options On Its Sleeves

FDA’s Ok to Roche’s Oral SMA Therapy; Roche’s Etrolizumab Mixed Results in Ulcerative Colitis; Secura receives rights to Copiktra from Verastem

Orchard licenses gene therapy tech from GSK; Glympse raises $46M; FDA voted to recommend Terlipressin; Breast Cancer research update

More Views & Analysis

FDA’s No to Intercept’s NASH Drug; Roche’s Phesgo gets approval; Gilead’s Remdesivir pricing

Dubai: A leading and exciting pharma hotspot

GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod

AZ sells EU rights for Schizophrenia to Cheplapharm; Astellas, Pandion unite to extract the potential of immunomodulation; Pear therapeutics on a journey to develop digital GI treatments with Ironwood

AZ announces positive results for durvalumab and tremelimumab; FDA nods to extend LILETTA’s use to prevent pregnancy; Gilead, Glympse Bio teams up to advance NASH clinical development

Rapt Therapeutics files IPO; Novartis stakes $80M for NASH

Global Burden of Liver cancer: Is it rising?

Subscribe to our Updates

Daily

Weekly

Monthly

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Gastroenterology

Ikena bags $120M; Terns raises $87M for NASH; Ribometrix Genentech Collaboration; Hologic acquires Biotheranostics

The State of Alternative Medicine In The Healthcare

Healthcare Delivery System: What lies in the future?

What Can Help Manage The Insufficient Pancreas?

Nutrition Intervention: Foods to take and foods to avoid when suffering from Gastroparesis

New Hopes; New Horizons: Gastroparesis Market Has Mighty Treatment Options On Its Sleeves

FDA’s Ok to Roche’s Oral SMA Therapy; Roche’s Etrolizumab Mixed Results in Ulcerative Colitis; Secura receives rights to Copiktra from Verastem

Orchard licenses gene therapy tech from GSK; Glympse raises $46M; FDA voted to recommend Terlipressin; Breast Cancer research update

FDA’s No to Intercept’s NASH Drug; Roche’s Phesgo gets approval; Gilead’s Remdesivir pricing

Dubai: A leading and exciting pharma hotspot

GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod

AZ sells EU rights for Schizophrenia to Cheplapharm; Astellas, Pandion unite to extract the potential of immunomodulation; Pear therapeutics on a journey to develop digital GI treatments with Ironwood

AZ announces positive results for durvalumab and tremelimumab; FDA nods to extend LILETTA’s use to prevent pregnancy; Gilead, Glympse Bio teams up to advance NASH clinical development

Rapt Therapeutics files IPO; Novartis stakes $80M for NASH

Global Burden of Liver cancer: Is it rising? ﻿

Subscribe to our Updates

Daily

Weekly

Monthly

Global Burden of Liver cancer: Is it rising?